galactosamine has been researched along with lupeol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, HI; Kim, JS; Kim, SJ; Kwak, JH; Lee, DU; Lee, SK; Lee, SM | 1 |
| Chen, L; Chen, Y; Gao, L; Huang, S; Lai, Y; Lv, Z; Mo, C; Wang, Y; Xie, S; Zeng, T; Zhou, C | 1 |
2 other study(ies) available for galactosamine and lupeol
| Article | Year |
|---|---|
Protective effects of lupeol against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure in mice.
Topics: Alanine Transaminase; Animals; Campanulaceae; Galactosamine; Interleukin-6; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Mice; Models, Biological; Molecular Structure; NF-kappa B; Pentacyclic Triterpenes; Plant Roots; Republic of Korea; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2014 |
Lupeol ameliorates LPS/D-GalN induced acute hepatic damage by suppressing inflammation and oxidative stress through TGFβ1-Nrf2 signal pathway.
Topics: Animals; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Down-Regulation; Galactosamine; Inflammation; Lipopolysaccharides; Mice, Inbred C57BL; NF-E2-Related Factor 2; Oxidative Stress; Pentacyclic Triterpenes; Transforming Growth Factor beta1; Up-Regulation; Zebrafish | 2021 |